Methylene blue
Methylene Blue is an intravenous injection used as an oxidation-reduction agent to treat conditions like methemoglobinemia. Available in 5 mg/mL strength from Zydus Lifesciences, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Methylene Blue is an intravenous injection used as an oxidation-reduction agent to treat conditions like methemoglobinemia. Available in 5 mg/mL strength from Zydus Lifesciences, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Methylene blue",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Methylene blue — ANDA 215636 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215636"
}
]
|
| identifier | ANDA215636 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"medications",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Methylene blue |
